News

ARC Group's 2026 Capital Markets & M&A Forum Concludes in Shanghai, Exploring New Pathways for Overseas Listings and Global Expansion
Exascale Labs Holdings Inc. Announces Closing of Business Combination with D. Boral ARC Acquisition I Corp. and Commencement of Trading on Nasdaq Under Ticker Symbol “XLAB”
Countdown Begins for ARC Group's 2026 Capital Markets and M&A Forum, Opening September 3 in Shanghai to Spotlight Overseas Listings, Cross-Border M&A, and the Global Expansion of Chinese Enterprises
Xinhua News Features ARC Group: Advising China’s Mid-Market on Global Expansion
ARC Group Successfully Concludes Capital Markets & M&A Forum Shenzhen 2025, Celebrating a Decade of Excellence
ARC Group Securities Becomes Nasdaq Member, Expanding Cross-Border Capital Markets Platform
ARC Group Securities Adds Underwriting License, Strengthening Global Capital Markets Platform
ARC Group Appointed as Exclusive Financial Advisor to XRP Healthcare M&A Holding Inc. on Definitive Agreement for Proposed Qualifying Transaction with AAJ Capital 3 Corp.
ARC Group Joins Celebration of the Best Workplaces™ in Hong Kong 2025
ARC Group Honoured as One of the Best Workplaces™ in Hong Kong 2025
ARC Group Celebrates New Chapter with Opening of Hong Kong Office
Capital Markets High Tea 2025: Navigating U.S. Listings and De-SPAC Strategies in Vietnam
Meey Group Selects ARC Group as Exclusive Financial Advisor for Planned U.S. IPO
ARC Group Earns Accreditation as a Great Place To Work-Certified™ Company!
XRP Healthcare Enters LOI for Qualifying Transaction with AAJ Capital 3 Corp., ARC Group Appointed as Exclusive Advisor
ARC Group Advises Cyclacel Pharmaceuticals on Proposed Share Exchange with fitters Sdn. Bhd.
D. Boral Capital and ARC Group Launch Series of SPACs
Sayward Capital Corp. and Technosteel Construction (L.L.C.) Enter Definitive Agreement for Business Combination
Capital Markets and M&A Forum 2025: 10th Anniversary Edition – Celebrating a Decade of Growth, Strategy, and Cross-Border Collaboration
ARC Group Advises BeLive Holdings on Successful Nasdaq IPO
ARC Group Supports Cyclacel Pharmaceuticals in $1 Million Private Placement of Convertible Preferred Stock
UPDATE: SEC Approves Listing Rule Changes
ARC Group's Team-Building Getaway: Strengthening Connections and Celebrating Success
ARC Group Advises on Share Purchase and Change of Control of Cyclacel Pharmaceuticals
ARC Group Successfully Concludes Capital Markets & M&A Forum Shanghai 2025, Celebrating a Decade of Excellence
ARC Group Celebrates a Decade of Excellence
ARC Group Advises Cyclacel Pharmaceuticals on $25M PIPE Financing
D. Boral Capital Secures Strategic Investments from ARC Group and an Institutional Investor
METAVISIO - THOMSON Computing Signs Engagement Agreement with ARC Group for U.S. Listing on Nasdaq or NYSE
Update: NASDAQ Proposed Listing Rule Change
ARC Group Proudly Sponsors Team ARC in the 16th China Cup International Regatta 2024
ARC Group Announces Successful IPO of Gelteq Limited on Nasdaq